Back to today’s briefing

Story perspectives

Texas Court Allows Novo Nordisk to Join Weight Loss Drug Lawsuit

3/7/2025

46 3

Summary

Story summary

A Texas federal court has granted Novo Nordisk the green light to join a lawsuit against compounding pharmacies that create cheaper alternatives to its weight loss medications, Ozempic and Wegovy. Judge Mark Pittman emphasized the importance of Novo's participation, citing safety concerns and the potential threat to its market amidst ongoing drug shortages and FDA controversies.

1 of 1

Story summary

A Texas federal court has granted Novo Nordisk the green light to join a lawsuit against compounding pharmacies that create cheaper alternatives to its weight loss medications, Ozempic and Wegovy. Judge Mark Pittman emphasized the importance of Novo's participation, citing safety concerns and the potential threat to its market amidst ongoing drug shortages and FDA controversies.